In May 2021, South Shore Hospital, part of South Shore Health, partnered with Boston Children’s Hospital on a new COVID-19 clinical trial. Patients admitted to the intensive care unit with severe COVID-19 pneumonia who require mechanical ventilation are invited to participate in this study. The...

Gem Gravure, an ink development company based in Hanover, has donated $10,000 to the Grayken Center for Treatment at South Shore Health. Learn more about what prompted this generous gift.

South Shore Hospital, part of South Shore Health, has received an Innovator Award from the editors of Healthcare Innovation for its groundbreaking work in Clinical Pharmacy Practice by improving the medication reconciliation process.

In support of National Prescription Drug Take-Back Day on October 26, South Shore Health has partnered with several local agencies including, Weymouth and Norwell Police Departments to provide safe, convenient and responsible means of disposing unwanted and expired medications.

This is the fourth consecutive verification for South Shore Hospital. As a Level II Trauma Center, the hospital is equipped to handle all critical injuries, 24 hours a day, seven days a week.

The new program is designed to provide intensive, structured care for individuals who need more support than traditional outpatient therapy, while still allowing participants to live at home and continue their daily routines.

For the fifth consecutive time, South Shore Hospital has earned an “A” safety grade rating from The Leapfrog Group, a designation that ranks the hospital among the safest in the Greater Boston area and the United States.

With support from its longstanding partnership with Best Automotive of Hingham, South Shore EMS has evolved into a premier emergency response team.

We're proud to celebrate the winners of The Friends' September calendar raffle, which helped raise close to $2,000 for pediatric programs at South Shore Hospital.

The purpose of the project is to create and maintain a national resource documenting and studying neurological complications of coronavirus disease, the illness caused by infection with the SARS-CoV-2 novel coronavirus.